Tag: Alnylam Pharmaceuticals
ATTR-CM Drug Race: Alnylam’s Entry
Alnylam's Amvuttra: A Game-Changer in the ATTR-CM Drug RaceAlnylam Pharmaceuticals has made waves in the pharmaceutical industry with the FDA's recent approval of their RNAi therapy, Amvuttra, for the treatment of transthyretin amyloid cardiomyopathy...
